MeSH tree: C10.228.140.380.100
The gut and brain are in constant conversation through a powerful biochemical signaling pathway. This two-way connection allows them to exchange signals that influence everything from digestion to emotional health, and studies ...
People with Alzheimer's disease who took the common supplement glucosamine were 25% more likely to die within five years than those who didn't. That's the key finding of a new study that my colleagues and I published in the ...
Jun 13, 2026
0
17
A popular over-the-counter supplement taken for joint pain might increase people's risk for Alzheimer's disease, a new study says.
Jun 11, 2026
0
248
Anyone who has had a bad night knows that they can feel "foggy" the next day. This fogginess may extend to our memory: remembering where we went, who we met or what happened during the encounter. Neuroscientist Robbert Havekes ...
Jun 11, 2026
0
41
People with mild cognitive impairment (MCI) are at higher risk of developing dementia. Indeed, many of them experience a gradual decline in cognitive performance over time. Smartphone- or tablet-based memory tests can capture ...
Jun 10, 2026
0
9
To function properly, neurons need to recycle cellular waste before it becomes toxic. When neurons can no longer do that, either due to aging or harmful genetic mutations, neurodegenerative disease can set in. One sign that ...
Jun 9, 2026
0
11
Researchers in the del Monte Lab at the Medical University of South Carolina (MUSC) are the first to observe defects in the protein repair system associated with the peculiar, misfolded protein plaques previously observed ...
Jun 9, 2026
0
4
Psilocybin is a naturally occurring psychoactive compound found in mushrooms of the Psilocybe genus. These mushrooms may have existed on Earth for nearly 65 million years, dating to the asteroid impact that caused the dinosaurs' ...
New research has found an association between taking glucosamine, a popular over-the-counter supplement used for joint pain, and a higher likelihood of progressing from mild cognitive impairment to Alzheimer's disease. The ...
Jun 9, 2026
0
426
"Compound 10" is how Ursula Quitterer refers to the chemical compound that her team has developed and that could slow the progression of Alzheimer's disease. Quitterer is a professor of molecular pharmacology at ETH Zurich ...
Jun 8, 2026
0
20
